Liotta & Petricoin receive funding for breast cancer research

(George Mason University) Lance Liotta, Co-Director, Applied Proteomics and Molecular Medicine, and Emanuel Petricoin, III, Co-Director, Applied Proteomics and Molecular Medicine, received $1,339,358 from the U.S. Department of the Army for a study of HER2+ breast cancer.

https://www.eurekalert.org/pub_releases/2021-02/gmu-lp020521.php

Source: EurekAlert! - Cancer - February 5, 2021 Category: Cancer & Oncology Source Type: news